SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028780
Filing Date
2022-08-09
Accepted
2022-08-09 16:37:34
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20220630.htm   iXBRL 10-Q 2550683
2 EX-10.1 xene-ex101_12.htm EX-10.1 38622
3 EX-31.1 xene-ex311_8.htm EX-31.1 22872
4 EX-31.2 xene-ex312_7.htm EX-31.2 22913
5 EX-32.1 xene-ex321_6.htm EX-32.1 12326
6 EX-32.2 xene-ex322_9.htm EX-32.2 11912
  Complete submission text file 0001564590-22-028780.txt   6507179

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20220630.xsd EX-101.SCH 41599
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20220630_cal.xml EX-101.CAL 39463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20220630_def.xml EX-101.DEF 91928
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20220630_lab.xml EX-101.LAB 292681
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20220630_pre.xml EX-101.PRE 209545
46 EXTRACTED XBRL INSTANCE DOCUMENT xene-10q_20220630_htm.xml XML 895552
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 221148957
SIC: 2834 Pharmaceutical Preparations